Alexion Pharmaceuticals Stock Price To Earning
Alexion Pharmaceuticals fundamentals help investors to digest information that contributes to Alexion Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Alexion Stock. The fundamental analysis module provides a way to measure Alexion Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alexion Pharmaceuticals stock.
Alexion |
Alexion Pharmaceuticals Company Price To Earning Analysis
Alexion Pharmaceuticals' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Alexion Pharmaceuticals Price To Earning | 58.24 X |
Most of Alexion Pharmaceuticals' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alexion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Alexion Pharmaceuticals has a Price To Earning of 58 times. This is 125.39% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The price to earning for all United States stocks is 102.79% lower than that of the firm.
Alexion Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alexion Pharmaceuticals' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alexion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Alexion Pharmaceuticals by comparing valuation metrics of similar companies.Alexion Pharmaceuticals is currently under evaluation in price to earning category among its peers.
Alexion Fundamentals
| Return On Equity | 4.43 | |||
| Return On Asset | 10.08 | |||
| Profit Margin | 10.89 % | |||
| Operating Margin | 52.12 % | |||
| Current Valuation | 39.17 B | |||
| Shares Outstanding | 221.02 M | |||
| Shares Owned By Insiders | 0.34 % | |||
| Shares Owned By Institutions | 88.27 % | |||
| Number Of Shares Shorted | 8.46 M | |||
| Price To Earning | 58.24 X | |||
| Price To Book | 3.19 X | |||
| Price To Sales | 6.33 X | |||
| Revenue | 6.26 B | |||
| Gross Profit | 5.52 B | |||
| EBITDA | 3.26 B | |||
| Net Income | 681.8 M | |||
| Cash And Equivalents | 3.47 B | |||
| Cash Per Share | 15.70 X | |||
| Total Debt | 2.88 B | |||
| Debt To Equity | 0.23 % | |||
| Current Ratio | 4.52 X | |||
| Book Value Per Share | 56.21 X | |||
| Cash Flow From Operations | 3.09 B | |||
| Short Ratio | 4.24 X | |||
| Earnings Per Share | 3.08 X | |||
| Price To Earnings To Growth | 1.46 X | |||
| Number Of Employees | 3.84 K | |||
| Beta | 1.28 | |||
| Market Capitalization | 39.66 B | |||
| Total Asset | 13.13 B | |||
| Retained Earnings | 5.01 B | |||
| Working Capital | 1.71 B | |||
| Current Asset | 2.43 B | |||
| Current Liabilities | 718.25 M | |||
| Z Score | 7.8 |
Pair Trading with Alexion Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alexion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alexion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to KLA Tencor could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace KLA Tencor when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back KLA Tencor - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling KLA Tencor to buy it.
The correlation of KLA Tencor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as KLA Tencor moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if KLA Tencor moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for KLA Tencor can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Alexion Stock
If you are still planning to invest in Alexion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alexion Pharmaceuticals' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |